From: Dialysis circuit clotting in critically ill patients with COVID-19 infection
COVID-19 | Control | p-value | |
---|---|---|---|
Number of CKRT circuits | 70 | 22 | Not applicable |
Number of patients | 12 | 15 | |
CKRT circuits per patient | 10 (2, 10) | 2 (2, 3.5) | |
Duration of CKRT, days | 6.5 (3, 17.5) | 3 (2, 3.5) | |
Number of circuits per patient-day of CKRT | 0.79 (0.49, 1.15) | 1 (0.78, 1) | |
Number of intermittent dialysis sessions | 32 | 18 | |
Age, years | 65 ± 14 | 58 ± 9 | 0.16 |
Male gender, n (%) | 9 (75) | 13 (87) | 0.39 |
ESKD, n (%) | 2 (17) | 8 (53) | 0.10 |
Weight, kg | 69 ± 17 | 73 ± 18 | 0.56 |
SOFAa | 10 ± 5 | 8 ± 4 | 0.23 |
Comorbidities | |||
HTN, n (%) | 8 (67) | 10 (67) | 1.00 |
IHD, n (%) | 4 (33) | 10 (67) | 0.13 |
DM, n (%) | 2 (17) | 11 (73) | < 0.05 |
Baseline medication use | |||
Antiplatelet, n (%) | 3 (25) | 8 (53) | 0.43 |
Anticoagulantb, n (%) | 1 (8) | 1 (7) |